These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 10320528

  • 1. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ.
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [Abstract] [Full Text] [Related]

  • 2. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA, Fledelius C, Christgau S, Christiansen C, Engsig M, Delmas P, Body JJ, Garnero P.
    Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
    [Abstract] [Full Text] [Related]

  • 3. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 4. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 5. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ, Gödde M, Brandenburg VM, Usadel KH, Stumpf UC.
    Adv Med Sci; 2009 Feb; 54(1):1-6. PubMed ID: 19482729
    [Abstract] [Full Text] [Related]

  • 6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M, Takahashi S, Ogata E.
    Anticancer Res; 2003 Mar 15; 23(5b):4095-9. PubMed ID: 14666607
    [Abstract] [Full Text] [Related]

  • 8. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 1996 Oct 15; 11(10):1531-8. PubMed ID: 8889854
    [Abstract] [Full Text] [Related]

  • 9. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K.
    J Rheumatol; 1999 Jun 15; 26(6):1250-6. PubMed ID: 10381038
    [Abstract] [Full Text] [Related]

  • 10. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS.
    Res Vet Sci; 2004 Aug 15; 77(1):29-39. PubMed ID: 15120950
    [Abstract] [Full Text] [Related]

  • 11. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep 15; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 12. Urinary markers of type I collagen degradation in the dog.
    Allen MJ, Allen LC, Hoffmann WE, Richardson DC, Breur GJ.
    Res Vet Sci; 2000 Oct 15; 69(2):123-7. PubMed ID: 11020362
    [Abstract] [Full Text] [Related]

  • 13. Cross-sectional evaluation of bone metabolism in men.
    Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD.
    J Bone Miner Res; 2001 Sep 15; 16(9):1642-50. PubMed ID: 11547833
    [Abstract] [Full Text] [Related]

  • 14. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
    Kaji T, Yasui T, Suto M, Mitani R, Morine M, Uemura H, Maeda K, Irahara M.
    Bone; 2007 Apr 15; 40(4):1088-94. PubMed ID: 17229597
    [Abstract] [Full Text] [Related]

  • 15. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
    Xue Y, Jia W, Zhang H, Dong J, Clemens JD, Tian X.
    Chin Med J (Engl); 1999 Feb 15; 112(2):149-52. PubMed ID: 11593583
    [Abstract] [Full Text] [Related]

  • 16. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H.
    Clin Lab; 2003 Feb 15; 49(5-6):203-7. PubMed ID: 15285175
    [Abstract] [Full Text] [Related]

  • 17. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar 15; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

  • 18. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P, Zamagni E, Cellini C, Parente R, Cangini D, Tacchetti P, Perrone G, Ceccolini M, Boni P, Tura S, Baccarani M, Cavo M.
    Eur J Haematol; 2006 May 15; 76(5):399-404. PubMed ID: 16480429
    [Abstract] [Full Text] [Related]

  • 19. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr 15; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 20. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
    Seibel MJ, Woitge HW, Pecherstorfer M, Karmatschek M, Horn E, Ludwig H, Armbruster FP, Ziegler R.
    J Clin Endocrinol Metab; 1996 Sep 15; 81(9):3289-94. PubMed ID: 8784085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.